# Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

> **NCT00030654** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 21 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** bicalutamide
- **DRUG:** docetaxel
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** estramustine phosphate sodium
- **DRUG:** flutamide
- **DRUG:** ketoconazole
- **DRUG:** paclitaxel
- **DRUG:** releasing hormone agonist therapy
- **DRUG:** vinblastine sulfate

## Key facts

- **NCT ID:** NCT00030654
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2005-02-04
- **Final completion:** 2005-02-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030654, "Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00030654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*